The Office of the Gene Technology Regulator (OGTR) is on its way to approving a licence application from PaxVax Australia (PaxVax) for the intentional release of a GMO vaccine consisting of live bacteria into the environment in Queensland, South Australia, Western Australia and Victoria.
According to the regulator, it qualifies as a limited and controlled release under section 50A of the Gene Technology Act 2000 (the Act).
PaxVax is seeking approval to conduct the clinical trial of a genetically modified live bacterial vaccine against cholera. Once underway the trial is expected to be completed within one year, with trial sites selected from local government areas (LGAs) in Queensland, South Australia, Victoria and Western Australia. PaxVax has proposed a number of control measures they say will restrict the spread and persistence of the GM vaccine and its introduced genetic material, however there is always a possibility of these restrictions failing and infecting wildlife and ecosystems.
Aerial vaccines have been used in the United States, directed towards animals by the use of plastic packets dropped by planes or helicopters. Sanofi (who is one of the largest vaccine manufacturers in the world) has subsidiary companies such as Merial Limited who manufacture Raboral, an oral live-virus that is poisonous to humans yet distributed to wildlife in masses.
In 2006, Michael Greenwood wrote an article for the Yale School of Public Health entitled, “Aerial Spraying Effectively Reduces Incidence of West Nile Virus (WNV) in Humans.” The article stated that the incidence of human West Nile virus cases can be significantly reduced through large scale aerial spraying that targets adult mosquitoes, according to research by the Yale School of Public Health and the California Department of Public Health.
Under the mandate for aerial spraying for specific vectors that pose a threat to human health, aerial vaccines known as DNA Vaccine Enhancements and Recombinant Vaccine against WNV may be tested or used to “protect” the people from vector infection exposures.
DNA vaccine enhancements specifically use Epstein-Barr viral capside’s with multi human complement class II activators to neutralize antibodies. The recombinant vaccines against WNV use Rabbit Beta-globulin or the poly (A) signal of the SV40 virus.
In early studies of DNA vaccines it was found that the negative result studies would go into the category of future developmental research projects in gene therapy.
During the studies of poly (A) signaling of the SV40 for WNV vaccines, it was observed that WNV will lie dormant in individuals who were exposed to chicken pox, thus upon exposure to WNV aerial vaccines the potential for the release of chicken pox virus would cause a greater risk to having adult onset Shingles.
March Against Monsanto is proud to announce the exclusive opportunityfor our supporters to participate in the first-ever Truth About Cancer live symposium. Join us for this extraordinary, live three day event (Oct. 14-16)! MAM supporters will have access to the top health and wellness experts who will be at the best of their best with incredible insight and health knowledge. Do not miss this live-changing opportunity! Sign up NOW by clicking here.
In the battle for health, education is key! We would like to invite March Against Monsanto supporters to an exclusive, free screening of The Truth About Cancer: A Global Quest. This powerful documentary will air from May 16th-May 24th at no cost to our loyal MAM supporters. Thank you for your continued support and we hope you utilize the life-saving information provided in this docu-series. Claim your free spot by clicking here.